Statement from FDA Commissioner Scott Gottlieb, MD on FDA advisory about deadly risks associated with kratom - FDA.gov

Channel NewsAsia

Statement from FDA Commissioner Scott Gottlieb, MD on FDA advisory about deadly risks associated with kratom FDA.gov The FDA has issued a public health advisory related to mounting concerns regarding risks associated with the use of kratom. Statement. The FDA is concerned about harmful unapproved products that have been crossing our borders in increasing numbers. FDA chief warns about kratom to treat opioid addiction; will seek more regulatory powerUSA TODAY FDA raises concerns about use of kratom for opioid addictionChannel NewsAsia all 3 news articles »

from Health - Google News http://ift.tt/2mqU4oc